切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (03) : 216 -220. doi: 10.3877/cma.j.issn.2095-3232.2018.03.012

所属专题: 文献

临床研究

原发性肝脏神经内分泌肿瘤诊治经验
魏荣光1, 周舟1, 吴浩然1, 程发辉1, 段小辉1, 杨建辉1, 田秉璋1, 周力学1, 毛先海1,()   
  1. 1. 410005 长沙,湖南省人民医院 湖南师范大学第一附属医院肝胆外科
  • 收稿日期:2018-03-18 出版日期:2018-06-10
  • 通信作者: 毛先海
  • 基金资助:
    湖南省教育厅重点项目(16A127); 湖南省卫生计生委科研计划项目(C2015-41)

Diagnosis and treatment experience of primary hepatic neuroendocrine neoplasm

Rongguang Wei1, Zhou Zhou1, Haoran Wu1, Fahui Cheng1, Xiaohui Duan1, Jianhui Yang1, Bingzhang Tian1, Lixue Zhou1, Xianhai Mao1,()   

  1. 1. Department of Hepatobiliary Surgery, Hunan People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha 410005, China
  • Received:2018-03-18 Published:2018-06-10
  • Corresponding author: Xianhai Mao
  • About author:
    Corresponding author: Mao Xianhai, Email:
引用本文:

魏荣光, 周舟, 吴浩然, 程发辉, 段小辉, 杨建辉, 田秉璋, 周力学, 毛先海. 原发性肝脏神经内分泌肿瘤诊治经验[J]. 中华肝脏外科手术学电子杂志, 2018, 07(03): 216-220.

Rongguang Wei, Zhou Zhou, Haoran Wu, Fahui Cheng, Xiaohui Duan, Jianhui Yang, Bingzhang Tian, Lixue Zhou, Xianhai Mao. Diagnosis and treatment experience of primary hepatic neuroendocrine neoplasm[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(03): 216-220.

目的

探讨原发性肝脏神经内分泌肿瘤(NEN)的诊治及疗效。

方法

回顾性分析2013年3月至2015年12月湖南省人民医院收治的10例原发性肝脏NEN患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男3例,女7例;年龄21~65岁,中位年龄45岁。根据2010版消化系统肿瘤WHO分类标准,神经内分泌瘤(NET)G2 6例,神经内分泌癌(NEC)4例。分析患者临床资料、影像学特点、治疗情况、肿瘤病理学特点及预后。

结果

患者右上腹痛5例,右上腹包块1例,乏力、纳差1例,其余3例患者由常规体检发现。8例影像学诊断为肝孤立性肿块,肝内多发占位2例。10例患者均经病理学检查诊断,其中3例术前活检确诊,7例术后病理学检查确诊。根治性切除6例,微波消融术1例,肝脏肿块切除及静脉化疗泵植入术1例,单纯行化疗1例,放弃治疗1例。截止至投稿日期无复发生存6例;1例术后1个月复发并腹膜后多发淋巴结转移,仍存活;死亡2例,其中1例穿刺活检后放弃治疗死亡,1例化疗1周期后死于肿瘤多发远处转移;失访1例。

结论

肝脏NEN无特异性临床表现,需病理学检查确诊,手术切除为首选治疗方法,对于肿块不可切除的患者可选择TACE、微波消融、化疗等方法。

Objective

To investigate the diagnosis, treatments for primary hepatic neuroendocrine neoplasm (NEN) and the efficacy.

Methods

Clinical data of 10 patients with primary hepatic NEN admitted in Hunan People's Hospital from March 2013 to December 2015 were analyzed retrospectively. The informed consents of all patients were obtained and the local ethical committee approval was received. There were 3 males and 7 females, aged 21-65 years old and the median age was 45 years old. According to the WHO classification for digestive system tumor 2010 version, there were 6 cases of neuroendocrine tumor (NET) G2, and 4 cases of neuroendocrine carcinoma (NEC). The clinical data, imaging characteristics, treatment, tumor pathological characteristics and prognosis of the patients were analyzed.

Results

Right upper abdominal pain was observed in 5 cases, right upper abdominal mass in 1 case, asthenia and anorexia1 in 1 case, and the remaining 3 cases were found with tumor when receiving routine physical examination. For imaging finding, 8 cases were diagnosed as isolated liver mass, and 2 were found with multiple masses in the liver. All of the 10 patients were confirmed by pathological examination, of which 3 were diagnosed by biopsy before operation, and 7 were confirmed with pathology after operation. 6 cases underwent radical resection, 1 case received microwave ablation, 1 underwent liver resection and intravenous chemotherapy pump implantation, 1 received chemotherapy alone and 1 abandoned treatment. To the submission date of this article, 6 cases survived without recurrence, 1 case suffered recurrence 1 month after operation with multiple lymph node metastases in the peritoneum and remained alive. 2 cases died, 1 of which died of no treatment after biopsy, 1 died of multiple distant metastases after 1 period of chemotherapy, and 1 lost follow-up.

Conclusions

There is no specific clinical manifestations of hepatic NEN. It should be confirmed by pathological examination. Surgical resection is the first choice for treatment. For patients with unresectable mass, TACE, microwave ablation and chemotherapy can be applied.

表1 10例原发性肝脏神经内分泌肿瘤患者临床资料
图1 一例原发性肝脏神经内分泌肿瘤患者腹部CT检查图
图2 一例原发性肝脏NEN患者肿瘤组织切片免疫组化染色图
[1]
Fenoglio LM, Severini S, Ferrigno D, et al. Primary hepatic carcinoid: a case report and literature review[J]. World J Gastroenterol,2009, 15(19):2418-2422.
[2]
Edmondson HA, National Research Council, Subcommittee on Oncology. Tumors of the liver and intrahepatic bile ducts (atlas of tumor pathology)[M].Washington: Armed Forces Institute of Pathology,1958.
[3]
Park CH, Chung JW, Jang SJ, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas[J]. J Gastroenterol Hepatol, 2012,27(8):1306-1311.
[4]
Wang LM, An SL, Wu JX. Diagnosis and therapy of primary hepatic neuroendocrine carcinoma: clinical analysis of 10 cases[J]. Asian Pac J Cancer Prev, 2014, 15(6):2541-2546.
[5]
Lambrescu IM, Martin S, Cima L, et al. Primary hepatic neuroendocrine tumor after 4 years tumor-free follow-up[J]. J Gastrointestin Liver Dis, 2015, 24(2): 241-244.
[6]
Sotiropoulos GC, Charalampoudis P, Delladetsima I, et al. Surgery for giant primary neuroendocrine carcinoma of the liver[J].J Gastrointest Surg, 2014, 18(4): 839-841.
[7]
Bosman F, Carneiro F. World Health Organization classification of tumours, pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2010.
[8]
Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor[J]. Ann Surg Oncol, 2003, 10(10):1171-1175.
[9]
朱雄增.胃肠胰神经内分泌肿瘤新分类的临床意义[J].中华胃肠外科杂志,2013,16(1):12-14.
[10]
Vinik AI, Chaya C. Clinical presentation and diagnosis of neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2016, 30(1):21-48.
[11]
Fraenkel M, Faggiano A, Valk GD. Epidemiology of neuroendocrine tumors[J]. Front Horm Res, 2015(44):1-23.
[12]
Camargo ÉS, Viveiros Mde M, Corrêa Neto IJ, et al. Primary hepatic carcinoid tumor: case report and literature review[J]. Einstein, 2014, 12(4):505-508.
[13]
Jia C, Zhang Y, Xu J, et al. Experience in primary hepatic neuroendocrine tumor[J]. Turk J Gastroenterol, 2012, 23 (5):546-551.
[14]
Quartey B. Primary hepatic neuroendocrine tumor: what do we know now? [J]. World J Oncol, 2011, 2(5):209-216.
[15]
Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes[J]. Cancer, 2015, 121(4): 589-597.
[16]
Lin CW, Lai CH, Hsu CC, et al. Primary hepatic carcinoid tumor: a case report and review of the literature[J]. Cases J, 2009, 2(1):90.
[17]
张文书,赵婧,纪元,等.肝原发性与转移性神经内分泌肿瘤的临床病理分析[J].中华肝胆外科杂志,2012,18(3):161-165.
[18]
Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases[J]. Pathol Int, 1999, 49(4):318-324.
[19]
Kellock T, Tuong B, Harris AC, et al. Diagnostic imaging of primary hepatic neuroendocrine tumors: a case and discussion of the literature[J]. Case Rep Radiol, 2014:156491.
[20]
Dala R, Shoosmith J, Lilenbaum R, et al. Primary hepatic neuroendocrine carcinoma: an underdiagnosed entity[J]. Ann Diagn Pathol, 2006, 10(1):28-31.
[21]
Hwang S, Lee YJ, Lee SG, et al. Surgical treatment of primary neuroendocrine tumors of the liver[J]. J Gastrointest Surg, 2008, 12(4):725-730.
[22]
Skagias L, Vasou O, Ntinis A, et al. Primary hepatic neuroendocrine tumor with exophytic growth: report of a case with diagnosis by fine needle aspiration biopsy[J]. Acta Cytol, 2010, 54(2):202-204.
[23]
Yalav O, Ülkü A, Akçam TA, et al. Primary hepatic neuroendocrine tumor: five cases with different preoperative diagnoses[J]. Turk J Gastroenterol, 2012, 23(3):272-278.
[24]
Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases[J]. Med Sci Monit, 2001, 7(4):746-750.
[25]
Taner T, Atwell TD, Zhang L, et al. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection[J]. HPB, 2013, 15(3):190-195.
[26]
Wängberg B, Nilsson O, Johanson V, et al. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumor[J]. Oncologist, 1997, 2(1):50-58.
[27]
Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor[J]. World J Gastroenterol, 2014, 20(39):14348-14358.
[28]
Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?[J].J Hepatol, 2007, 47(4):460-466.
[29]
Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors[J]. Liver Transpl, 2007, 13(3):327-333.
[30]
Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database[J]. Arch Surg, 2011, 146 (8):953-958.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[5] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[6] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[7] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[8] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[9] 李婷婷, 吴荷玉, 张悦, 程康, 张晓芳, 程娅婵. 复合保温策略在老年腹腔镜解剖性肝切除术中的应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 522-525.
[10] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[11] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[12] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[13] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[14] 马俊永, 王毅州, 李锡锋, 吴雅丽, 张小峰. 浅谈腹腔镜肝切除术出血防控策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 495-498.
[15] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
阅读次数
全文


摘要